
Haystack Dx is a medical technology company specializing in next-generation neuromuscular diagnostics. They advance electrodiagnostic medicine using proprietary needle technology and AI-powered algorithms to obtain electrophysiological, histological, and compositional data of nerves and muscles, enabling tracking of disease progression and therapy effects. Their impedance-electromyography technology offers a quantifiable, AI-powered solution for assessing conditions impacting neuromuscular disorders like muscular dystrophy and Lou Gehrig’s disease, without altering clinical procedures or test duration. The company aims to improve the diagnosis, monitoring, and therapeutic treatment of patients with nerve and muscle disorders, addressing a global market affected by over 100 million people with such conditions.

Haystack Dx is a medical technology company specializing in next-generation neuromuscular diagnostics. They advance electrodiagnostic medicine using proprietary needle technology and AI-powered algorithms to obtain electrophysiological, histological, and compositional data of nerves and muscles, enabling tracking of disease progression and therapy effects. Their impedance-electromyography technology offers a quantifiable, AI-powered solution for assessing conditions impacting neuromuscular disorders like muscular dystrophy and Lou Gehrig’s disease, without altering clinical procedures or test duration. The company aims to improve the diagnosis, monitoring, and therapeutic treatment of patients with nerve and muscle disorders, addressing a global market affected by over 100 million people with such conditions.